{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T10:03:38Z","timestamp":1785578618657,"version":"3.56.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01438","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T05:26:14Z","timestamp":1597814774000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A"],"prefix":"10.3389","volume":"10","author":[{"given":"Hailing","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Betancur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"ter Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell."},{"key":"B2","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.it.2015.02.003","article-title":"The STING pathway and the T cell-inflamed tumor microenvironment","volume":"36","author":"Woo","year":"2015","journal-title":"Trends Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/bs.ai.2015.12.003","article-title":"Tumor and host factors controlling antitumor immunity and efficacy of cancer immunotherapy","volume":"130","author":"Spranger","year":"2016","journal-title":"Adv Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1053\/j.seminoncol.2015.05.011","article-title":"The next hurdle in cancer immunotherapy: overcoming the non-T-cell-inflamed tumor microenvironment","volume":"42","author":"Gajewski","year":"2015","journal-title":"Semin Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4049\/jimmunol.1601145","article-title":"Intratumoral delivery of immunotherapy-act locally, think globally","volume":"198","author":"Aznar","year":"2017","journal-title":"J Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1158\/1078-0432.CCR-18-2690","article-title":"For whom the cell tolls? Intratumoral treatment links innate and adaptive immunity","volume":"25","author":"Marquez-Rodas","year":"2019","journal-title":"Clin Canc Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1526250","DOI":"10.1080\/2162402X.2018.1526250","article-title":"Trial watch: toll-like receptor agonists in cancer immunotherapy","volume":"7","author":"Smith","year":"2018","journal-title":"Oncoimmunology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1172\/JCI8541","article-title":"Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide","volume":"105","author":"Lien","year":"2000","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/imm.12787","article-title":"Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses","volume":"152","author":"Yi","year":"2017","journal-title":"Immunology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e16333","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"Coler","year":"2011","journal-title":"PLoS ONE"},{"key":"B13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.smim.2018.10.004","article-title":"Correlates of GLA family adjuvants' activities","volume":"39","author":"Reed","year":"2018","journal-title":"Semin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e88979","DOI":"10.1371\/journal.pone.0088979","article-title":"GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza","volume":"9","author":"Clegg","year":"2014","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"17585","DOI":"10.1073\/pnas.1207308109","article-title":"Adjuvant solution for pandemic influenza vaccine production","volume":"109","author":"Clegg","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41541-020-0201-x","article-title":"Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors","volume":"5","author":"Albershardt","year":"2020","journal-title":"NPJ Vaccines"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1158\/1078-0432.ccr-18-0469","article-title":"Intratumoral G100, a TLR4 agonist, induces antitumor immune responses and tumor regression in patients with merkel cell carcinoma","volume":"25","author":"Bhatia","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/CJI.0000000000000067","article-title":"Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy","volume":"38","author":"Odegard","year":"2015","journal-title":"J Immunother"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/eji.201646399","article-title":"Antigen presentation by B cells guides programing of memory CD4+ T-cell responses to a TLR4-agonist containing vaccine in mice","volume":"46","author":"Dubois","year":"2016","journal-title":"Eur J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ejca.2016.09.010","article-title":"Turning tumour cells into antigen presenting cells: the next step to improve cancer immunotherapy?","volume":"68","author":"de Charette","year":"2016","journal-title":"Eur J Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e641e51","DOI":"10.1111\/j.1365-2567.2009.03052.x","article-title":"The immunogenicity of L1210 lymphoma clones correlates with their ability to function as antigen-presenting cells","volume":"128","author":"Cycon","year":"2009","journal-title":"Immunology."},{"key":"B22","doi-asserted-by":"publisher","first-page":"17e23","DOI":"10.1016\/S0165-2478(01)00189-4","article-title":"Enhancement of antigen-presenting ability of B lymphoma cells by immunostimulatory CpG-oligonucleotides and anti-CD40 antibody","volume":"77","author":"Chen","year":"2001","journal-title":"Immunol Lett"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1259e68","DOI":"10.1002\/1097-0142(20000915)89:6<1259::AID-CNCR10>3.0.CO;2-G","article-title":"B7 costimulatory molecules from malignant cells in patients with B-cell chronic lymphoproliferative disorders trigger T-cell proliferation","volume":"89","author":"Trentin","year":"2000","journal-title":"Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8200e4","DOI":"10.1073\/pnas.92.18.8200","article-title":"Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity","volume":"92","author":"Schultze","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.immuni.2015.11.006","article-title":"Toll-like receptor 4 engagement on dendritic cells restrains phago-lysosome fusion and promotes cross-presentation of antigens","volume":"43","author":"Alloatti","year":"2015","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12026-014-8523-2","article-title":"Toll-like receptors and B cells: functions and mechanisms","volume":"59","author":"Buchta","year":"2014","journal-title":"Immunol Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1158\/1538-7445.AM2017-2947","article-title":"Intratumoral injection of the toll-like receptor 4 agonist G100 induces a T-cell response in the soft tissue sarcoma microenvironment [abstract]","author":"Seo","year":"2017","journal-title":"Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.86.1.282","article-title":"B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells","volume":"86","author":"Weiss","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1073\/pnas.95.3.1178","article-title":"Induction of antigen-specific T cell anergy: an early event in the course of tumor progression","volume":"95","author":"Staveley-O'Carroll","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e51618","DOI":"10.1371\/journal.pone.0051618","article-title":"Molecular and cellular response profiles induced by the TLR4 agonist-based adjuvant Glucopyranosyl Lipid A","volume":"7","author":"Lambert","year":"2012","journal-title":"PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.4049\/jimmunol.179.4.2493","article-title":"Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself","volume":"179","author":"Li","year":"2007","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41591-019-0410-x","article-title":"Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination","volume":"25","author":"Hammerich","year":"2019","journal-title":"Nat Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/sj.leu.2404225","article-title":"Toll-like receptors mediate proliferation and survival of multiple myeloma cells","volume":"20","author":"Bohnhorst","year":"2006","journal-title":"Leukemia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.yexmp.2010.08.003","article-title":"Differential expression of Toll-like receptors in follicular lymphoma, diffuse large B-cell lymphoma and peripheral T-cell lymphoma","volume":"89","author":"Smith","year":"2010","journal-title":"Exp Mol Pathol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01438\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T05:26:17Z","timestamp":1597814777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01438\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":34,"alternative-id":["10.3389\/fonc.2020.01438"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01438","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"article-number":"1438"}}